Skip to content
Clinical Trials – home
Therapeutic area

Investigations – page 4

  • 79 clinical trials
  • 29 recruiting
  • 93 conditions
  • 21 countries

Conditions in this area

93 conditions with trials, the busiest first

Clinical trials in Investigations

79 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

79 clinical trials

SARS-CoV-2 test positive

Not yet recruiting

Study on Montelukast for COVID-19 Patients at Higher Risk of Complications in the Community

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Montelukast
  • Sponsor:Universiteit Maastricht

Antiphospholipid antibodies

Not yet recruiting

Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Hydroxychloroquine Sulfate
  • Sponsor:Region Hovedstaden

Study on the Impact of LF111 and Drospirenone on Bone Health in Adolescent and Adult Women Using Oral Contraceptives

Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Chemo Research S.L.

Drug level

Not recruiting

Effect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Ethinylestradiol
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Effect of itraconazole on the pharmacokinetics of BI 1584862 in healthy male volunteers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Itraconazole
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Effect of multiple doses of BI 1358894 on the pharmacokinetics of ethinylestradiol and drospirenone in healthy women

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 685509
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Study of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Zongertinib
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Study of BI 1810631 (C‑14) oral solution, BI 1810631 (C‑14) IV microtracer, and BI 1810631 tablet to assess absorption and metabolism in healthy men

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Zongertinib
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Study of BI 1291583 oral tablets (1 mg and 5 mg) and intravenous microtracer in healthy male volunteers

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Pharmacokinetic Study of BI 764198 XX (C‑14) and [4-(6‑aminopyridazin‑3‑yl)piperidin‑1‑yl][5-(4‑fluorophenoxy)-4‑methoxypyridin‑2‑yl]methanone in Healthy Men

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim International GmbH

Drug level

Not recruiting

Effect of BI 1015550 on blood levels of nintedanib and pirfenidone in healthy men

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim International GmbH

Substances studied in this area

The therapies tested most often in Investigations trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.